Harrison.ai has announced a strategic partnership with Apollo Radiology International (ARI) teleradiology to deploy its Chest X-ray (CXR) and Brain CT (CTB) AI tools across ARI’s global reporting offerings.
CTB is trained to detect up to 130 findings on noncontrast head CT, while CXR is designed to detect up to 124 findings, according to the firm. Both feature embedded triage capability.
The company has obtained various regulatory clearances, including U.S. Food and Drug Administration 510(k)s and breakthrough device designations in the U.S. Cleared for sale in 40 countries, the software tools may be useful as second readers, for improving operational efficiency, and supporting out-of-hours care, the company added.
